Form 4 holding
Director
IMARA Inc.
- Security class
- Common Stock
- Shares / value
- 229,224
- Estimated value
- $3,469,305
- Report date
- 02 Jun 2022
- Price
- $15.14
- Ownership
- Direct
David M. Mott - Director at Enliven Therapeutics, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Director
- Issuer Symbol
- ELVN on Nasdaq
- All Insider Reports
- All Insider Reports
There are no Buy or Sell transactions made by David M. Mott since 18 May 2025
Holdings reported by David M. Mott for Enliven Therapeutics, Inc.
Form 4 holding
Director
IMARA Inc.
- Security class
- Stock Options (Right to Buy)
- Shares / value
- 8,500
- Estimated value
- Report date
- 02 Jun 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by David M. Mott for Enliven Therapeutics, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.